Rasch analysis of clinical outcome measures in spinal muscular atrophy-Reference-Cited by-同舟云学术

Rasch analysis of clinical outcome measures in spinal muscular atrophy

Published:2013-07-26 Issue:3 Volume:49 Page:422-430
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Cano Stefan J.¹,Mayhew Anna²,Glanzman Allan M.³,Krosschell Kristin J.⁴,Swoboda Kathryn J.⁵,Main Marion⁶,Steffensen Birgit F.⁷,Bérard Carole⁸,Girardot Françoise⁸,Payan Christine A.M.⁹,Mercuri Eugenio¹⁰,Mazzone Elena¹⁰,Elsheikh Bakri¹¹,Florence Julaine¹²,Hynan Linda S.¹³,Iannaccone Susan T.¹⁴,Nelson Leslie L.¹⁵,Pandya Shree¹⁶,Rose Michael¹⁷,Scott Charles¹⁸,Sadjadi Reza¹⁹,Yore Mackensie A.²⁰,Joyce Cynthia²⁰,Kissel John T.²¹,

Affiliation:

1. Clinical Neurology Research Group, Room N13 ITTC Building; Peninsula College of Medicine and Dentistry; Tamar Science Park Plymouth United Kingdom

2. Newcastle Muscle Team; Institute of Human Genetics, International Centre for Life; Central Parkway Newcastle United Kingdom

3. Department of Physical Therapy; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania USA

4. Department of Physical Therapy and Human Movement Sciences; Feinberg School of Medicine Northwestern University; Chicago Illinois USA

5. University of Utah School of Medicine; Salt Lake City Utah USA

6. Great Ormond Street Children's Hospital for the Dubowitz Neuromuscular Center; London England

7. Rehabiliterings Center for Muskelsvind; Aarhus Denmark

8. Centre Hospitalier; Lyon Sud France

9. Department de Pharmacologie Clinique; Hôpital Pitié-Salpêtrière; Assistance Publique-Hôpitaux de Paris (AP-HP) Paris France

10. Department of Paediatric Neurology; Neuropsichiatra Infantile; Polclinico Gemell, Largo Gemelli Rome Italy

11. Division of Neuromuscular Medicine, Department of Neurology; The Ohio State University; Columbus Ohio USA

12. Neuromuscular Division; Department of Neurology; Washington University School of Medicine; St. Louis Missouri USA

13. Departments of Clinical Sciences (Biostatistics) and Psychiatry; University of Texas Southwestern Medical Center; Dallas Texas USA

14. Pediatrics and Neurology and Neurotherapeutics; University of Texas Southwestern Medical Center; Pediatric Neurology, Children's Medical Center Ambulatory Care Pavilion Dallas Texas USA

15. Department of Physical Therapy; University of Texas Southwestern Medical Center; Dallas Texas USA

16. Department of Neurology; University of Rochester School of Medicine and Dentistry; Rochester New York USA

17. Department of Neurology; King's College Hospital; Denmark Hill London United Kingdom

18. CBS Squared, Inc; Fort Washington, PA for Project Cure; USA

19. Department of Neurology; University of Virginia; Charlottesville Virginia USA

20. Spinal Muscular Atrophy Foundation; New York New York USA

21. Departments of Neurology and Pediatrics; The Ohio State University/Nationwide Children's Hospital; 395 W. 12th Avenue Columbus Ohio 43210 USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.23937/fullpdf

Reference61 articles.

1. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens;Sugarman;Eur J Hum Genet,2012

2. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease;Monani;Neuron,2005

3. Natural history in proximal spinal muscular atrophy;Zerres;Arch Neurol,1995

4. Drug treatment for spinal muscular atrophy Type I;Bosboom;Cochrane Database Syst Rev,2009

5. Drug treatment for spinal muscular atrophy types II and III;Bosboom;Cochrane Database Syst Rev,2009

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy;Journal of Neuromuscular Diseases;2024-09-03

2. Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3.;Neuromuscular Disorders;2024-08

3. Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3;Journal of Neuromuscular Diseases;2024-04-30

4. Design and Validation of a Clinical Outcome Measure for Adolescents and Adult Patients with Spinal Muscular Atrophy: SMA Life Study Protocol;Neurology and Therapy;2024-01-05

5. A Mixed-method Approach to Develop an Ambulatory Module of the SMA Independence Scale;Journal of Neuromuscular Diseases;2023-11-07